SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J.B. Chemicals & Pharmaceuticals informs about disclosure of related party transactions

25 May 2023 Evaluate

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, J.B. Chemicals & Pharmaceuticals has informed that it enclosed disclosure of related party transactions for the second half of the financial year 2022-23.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

2196.00 0.05 (0.00%)
18-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.95
Dr. Reddys Lab 1271.00
Cipla 1358.90
Zydus Lifesciences 1074.30
Lupin 2331.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: